The Lancet
Ursula Hofer is an accomplished editor and medical professional with extensive experience in the fields of infectious diseases and microbiology. Currently serving as the Editor-in-Chief of The Lancet Infectious Diseases since August 2022, Ursula has held key editorial positions at Nature Publishing Group, including Chief Editor of Nature Reviews Microbiology. Ursula's previous roles range from project management in medical education at Ludwig Maximillians University to consultancy in healthcare and biotechnology. Notably, Ursula has a strong background in research, including a PhD in Molecular Biology from the University of Zurich, coupled with a medical degree from the University of Berne. Ursula has contributed significantly to scientific literature and has experience in clinical practice as an immunologist.
The Lancet
The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (Oct 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.